40
1
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T28353 |
PDP-EA
|
FAAH | Metabolism; Neuroscience |
PDP-EA 是脂肪酸酰胺水解酶 (FAAH) 的激活剂,可增强 FAAH 的酰胺水解酶活性。 | |||
T18531 |
PDP-Pfp
|
Others | Others |
PDP-Pfp is a reducible ADC linker primarily utilized for targeting agents aimed at the extracellular loop 1 (ECL1) of TM4SF1, a member of the transmembrane 4 L6 family, as supported by reference [1]. | |||
T18530 |
PDP-C1-Ph-Val-Cit
|
Others | Others |
PDP-C1-Ph-Val-Cit is a cleavable ADC linker used for antibody-drug conjugates (ADCs). | |||
T74302 | DSPE-PEG-PDP | ||
DSPE-PEG-PDP 是一种磷脂 PEG 偶联物,可用于药物递送应用。 | |||
TP2036L |
DPDPE TFA (88373-73-3 free base)
DPDPE TFA |
Opioid Receptor | Endocrinology/Hormones; GPCR/G Protein; Neuroscience |
DPDPE TFA 是选择性 δ-阿片受体激动剂肽,在体内具有镇痛作用。 | |||
T19955 |
Biotin-HPDP
Pyridyldisulfide-biotin,Pyridyldithiol-biotin |
Others | Others |
Biotin-HPDP (Pyridyldithiol-biotin) 是一种巯基反应性生物素化试剂。 | |||
T6741 |
SPDP
SPDP Crosslinker |
Others | Others |
SPDP 是一种短链交联剂,用于通过 NHS 酯和吡啶基二硫醇反应基团与半胱氨酸巯基形成可切割(可还原)的二硫键,实现胺与巯基的共轭。它是一种可降解的 ADC 连接剂,可用于合成抗体偶联药物。 | |||
T18709 | SPDP-PEG12-acid | Others | Others |
SPDP-PEG12-acid is a cleavable 12-unit polyethylene glycol (PEG) linker utilized for the synthesis of antibody-drug conjugates (ADCs)[1]. | |||
T18711 |
SPDP-PEG24-acid
|
Others | Others |
SPDP-PEG24-acid is a PEG-based linker for PROTACs which joins two essential ligands, crucial for forming PROTAC molecules. This linker enables selective protein degradation by leveraging the ubiquitin-proteasome system within cells. | |||
T77286 |
DSPE-SPDP
|
||
DSPE-SPDP,一种磷脂分子,能够在水中自行定向并形成脂质双层,适用于多种生化研究。 | |||
T37235 |
(±)16(17)-EpDPA
(±)16,17-EpDPE,(±)16,17 EDP,(±)16,17-epoxy Docosapentaenoic Acid,(±)16,17-epoxy DPA,(±)16(17)-EpDPA |
||
EDHF (endothelium-derived hyperpolarizing factor) is an unidentified mediator released from vascular endothelial cells in response to acetylcholine and bradykinin which is distinct from the NOS- (nitric oxide) and COX-derived (prostacyclin) vasodilators.[1],[2]Cytochrome P450 (CYP450) metabolism of polyunsaturated fatty acids produces epoxides such as (±)14(15)-EET which are prime candidates for the actual active mediator.[3] However, the CYP450 metabolites of eicosapentaenoic acid and docosahex... | |||
T37241 |
(±)4(5)-EpDPA methyl ester
|
||
(±)4(5)-EpDPA methyl ester is a derivative of (±)4(5)-EpDPA which is stable enough to ship and handle routinely. The active free acid can be regenerated from the methyl ester by careful base hydrolysis. (±)4(5)EpDPA is a CYP450 metabolite of DHA which can be further metabolized to the diol metabolite. There are no published reports on the biological activity of (±)4(5)-EpDPA methyl ester at this time. | |||
T16915 |
SPDP-C6-NHS ester
|
Others | Others |
SPDP-C6-NHS ester is an alkyl/ether-based linker utilized in the synthesis of PROTACs[1]. | |||
T18715 |
SPDP-PEG7-acid
|
Others | Others |
SPDP-PEG7-acid is a PEG-based linker for PROTACs which joins two essential ligands, crucial for forming PROTAC molecules. This linker enables selective protein degradation by leveraging the ubiquitin-proteasome system within cells. | |||
T16918 |
SPDP-PEG6-NHS ester
|
Others | Others |
SPDP-PEG6-NHS ester is a PEG-based linker for PROTACs which joins two essential ligands, crucial for forming PROTAC molecules. This linker enables selective protein degradation by leveraging the ubiquitin-proteasome system within cells. | |||
T18714 |
SPDP-PEG5-acid
|
Others | Others |
SPDP-PEG5-acid is a PEG-based linker for PROTACs which joins two essential ligands, crucial for forming PROTAC molecules. This linker enables selective protein degradation by leveraging the ubiquitin-proteasome system within cells. | |||
T15724 |
LC-PEG8-SPDP
|
Others | Others |
LC-PEG8-SPDP is a cleavable ADC linker used for the antibody-drug conjugates (ADCs)[1]. | |||
T36218 |
19R(20S)-EpDPA
|
||
19R(20S)-EpDPA is an oxylipin and a metabolite of docosahexaenoic acid .1,2It is formed from DHA by various cytochrome P450 (CYP) isoforms in a stereoselective manner.219R(20S)-EpDPA (30 nM) prevents calcium-induced increases in the spontaneous beating of isolated neonatal rat cardiomyocytes (NRCMs).3 1.Cinelli, M.A., Yang, J., Scharmen, A., et al.Enzymatic synthesis and chemical inversion provide both enantiomers of bioactive epoxydocosapentaenoic acidsJ. Lipid Res.59(11)2237-2252(2018) 2.Lucas... | |||
T18535 |
PEG4-SPDP
|
Others | Others |
PEG4-SPDP is a cleavable ADC linker used for the antibody-drug conjugates (ADCs). | |||
TP2036 |
DPDPE
|
Opioid Receptor | Endocrinology/Hormones; GPCR/G Protein; Neuroscience |
DPDPE 是选择性 δ-阿片受体激动剂肽,在体内具有镇痛作用。 | |||
T17834 |
DM4-SPDP
|
Others | Others |
DM4-SPDP, a drug-linker conjugate, integrates the antitubulin agent DM4 with the linker SMCC, facilitating the creation of antibody drug conjugates[1]. Additionally, SPDP serves as a short-chain crosslinker enabling amine-to-sulfhydryl conjugation, leveraging NHS-ester and pyridyldithiol groups to establish cleavable (reducible) disulfide bonds with cysteine sulfhydryls[2][3]. | |||
T35493 |
(±)10(11)-EpDPA
|
||
Cytochrome P450 metabolism of polyunsaturated fatty acids produces numerous bioactive epoxide regioisomers. (±)10(11)-EpDPA is a docosahexaenoic acid epoxygenase metabolite, derived via epoxidation of the 10,11-double bond of DHA. It has been detected in rat brain and spinal cord, as well as human serum, and acts as a substrate for soluble epoxide hydrolase with a Km value of 5.1 μM. (±)10(11)-EpDPA and other epoxy metabolites of DHA are reported to demonstrate antihyperalgesic activity in infla... | |||
T18733 |
Sulfo-SPDP-C6-NHS sodium
|
Others | Others |
Sulfo-SPDP-C6-NHS sodium is a sodium salt form of a cleavable ADC linker employed in the synthesis of antibody-drug conjugates (ADCs)[1]. | |||
T18710 |
SPDP-PEG12-NHS ester
|
Others | Others |
SPDP-PEG12-NHS ester is a PEG-based linker for PROTACs which joins two essential ligands, crucial for forming PROTAC molecules. This linker enables selective protein degradation by leveraging the ubiquitin-proteasome system within cells. | |||
T18716 |
SPDP-PEG9-acid
|
Others | Others |
SPDP-PEG9-acid is a PEG-based linker for PROTACs which joins two essential ligands, crucial for forming PROTAC molecules. This linker enables selective protein degradation by leveraging the ubiquitin-proteasome system within cells. | |||
T16916 |
SPDP-PEG4-acid
|
Others | Others |
SPDP-PEG4-acid is a PEG-based linker for PROTACs which joins two essential ligands, crucial for forming PROTAC molecules. This linker enables selective protein degradation by leveraging the ubiquitin-proteasome system within cells. | |||
T18712 |
SPDP-PEG24-NHS ester
|
Others | Others |
SPDP-PEG24-NHS ester is a PEG-based linker for PROTACs which joins two essential ligands, crucial for forming PROTAC molecules. This linker enables selective protein degradation by leveraging the ubiquitin-proteasome system within cells. | |||
T16917 |
SPDP-PEG4-NHS ester
|
Others | Others |
SPDP-PEG4-NHS ester is a PEG-based linker for PROTACs which joins two essential ligands, crucial for forming PROTAC molecules. This linker enables selective protein degradation by leveraging the ubiquitin-proteasome system within cells. | |||
T37238 |
(±)19(20)-EpDPA
|
||
EDHF (endothelium-derived hyperpolarizing factor) is an unidentified mediator released from vascular endothelial cells in response to acetylcholine and bradykinin which is distinct from the NOS- (nitric oxide) and COX-derived (prostacyclin) vasodilators. Cytochrome P450 (CYP450) metabolism of polyunsaturated fatty acids produces epoxides such as (±)14(15)-EpETrE which are prime candidates for the actual active mediator. However, the CYP450 metabolites of eicosapentaenoic acid and docosahexaenoic... | |||
T35497 |
(±)7(8)-EpDPA
|
||
Docosahexaenoic acid is the most abundant ω-3 fatty acid in neural tissues, especially in the brain and retina. (±)7(8)-EpDPA is an epoxide derivative of DHA that is generated by the action of cytochrome P450 epoxygenases. It is naturally occurring in plasma and brain and spinal cord tissues and is increased following dietary supplementation with ω-3 fatty acids. (±)7(8)-EpDPA and other epoxy metabolites of DHA modulate receptor and channel activities to evoke diverse effects, such as promoting ... | |||
T18725 |
Sulfo-LC-SPDP
|
Others | Others |
Sulfo-LC-SPDP is a heterobifunctional crosslinker characterized by its thiol-cleavable and membrane impermeable properties. | |||
T60528 | PDPOB | ||
PDPOB 是一种苯基羧酸衍生物,具有用于脑缺血研究的潜力。PDPOB 被证明可以防止 SH-SY5Y 细胞中 OGD/R 诱发的多方面神经元退化,减轻的线粒体功能障碍、氧化应激和细胞凋亡证明了这一点。 | |||
T18525 |
PC SPDP-NHS carbonate ester
|
Others | Others |
PC SPDP-NHS carbonate ester is a cleavable linker compound utilized in the synthesis of antibody-drug conjugates (ADCs)[1]. | |||
T38597 |
SPDP-sulfo
|
||
SPDP-sulfo is a cleavable linker vital in ADC synthesis. SPDP-sulfo joins cytotoxic drugs to antibodies, enabling precise delivery to cells or proteins. The cleavable nature ensures controlled drug release, optimizing ADC effectiveness. | |||
T33904 |
PDPH Crosslinker
PDPH Cross linker,SPDP Hydrazide,PDPH Cross-linker |
||
PDPH crosslinker(SPDP Hydrazide) is a lytic heterobisfunctional protein crosslinker. | |||
T35496 |
(±)13(14)-EpDPA
|
||
Cytochrome P450 metabolism of polyunsaturated fatty acids produces numerous bioactive epoxide regioisomers. (±)13(14)-EpDPA is a docosahexaenoic acid epoxygenase metabolite, derived via epoxidation of the 13,14-double bond of DHA. It has been detected in rat brain and spinal cord and is a preferred substrate for soluble epoxide hydrolase with a Km value of 3.2 μM. (±)13(14)-EpDPA demonstrates antihyperalgesic activity in inflammatory and neuropathic pain models. (±)13(14)-EpDPA and other epoxy m... | |||
T18708 |
SPDP-C6-Gly-Leu-NHS ester
|
Others | Others |
SPDP-C6-Gly-Leu-NHS ester is a cleavable linker employed in the synthesis of antibody-drug conjugates (ADCs)[1]. | |||
T18713 |
SPDP-PEG36-NHS ester
|
Others | Others |
SPDP-PEG36-NHS ester is a PEG ADC linker consisting of 36 units, characterized by cleavability. It plays a crucial role in the synthesis of antibody-drug conjugates (ADCs)[1]. | |||
T14908 |
CCT367766
|
PROTACs | PROTAC |
CCT367766 是一种强效的、基于 PROTAC 的第三代异多功能 pirin 靶向蛋白降解探针(PDP),能在低浓度下消耗 pirin 蛋白的表达。CCT367766 对 CRBN-DDB1 复合物的IC50 值为 490 nM。CCT367766 与重组 pirin 和 CRBN 具有良好的亲和力,Kd 值分别为 55 nM 和 120 nM。CCT367766 是一种有效的口服活性蛋白,在低浓度时就可以减少 pirin 蛋白的表达。 | |||
T77915 |
CCT367766 formic
|
PROTACs | PROTAC |
CCT367766 formic 是一款有效的口服第三代异功能蛋白降解探针(PROTAC),基于Cereblon配体,能在低浓度降低pirin蛋白表达。该化合物对CRBN-DDB1复合物具中等亲和力,IC50值为490 nM;同时,对重组pirin和CRBN的亲和力良好,Kd值分别为55 nM和120 nM。CCT367766 formic作为化学工具,对研究某些未开发蛋白质具有重要价值。 |
Cat. No. | Product Name | Species | Expression System |
---|---|---|---|
TMPY-00714 |
CD5L Protein, Mouse, Recombinant (His)
42010,AAC-11,Sp-alpha,Pdp,Api6,AI047839,CT2,CD5 mol... |
Mouse | HEK293 Cells |
CD5L Protein, Mouse, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 38 kDa and the accession number is Q9QWK4. |